Brief: Lyra Therapeutics Reports Q1 2023 Financial Results, Provides Corporate Update
12/05/2023 13:14
May 12 (Reuters) - Lyra Therapeutics Inc LYRA.O :
* LYRA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* LYRA THERAPEUTICS INC - DATA FROM BEACON PHASE 2 TRIAL OF
LYR-220 IN POST-SURGICAL CRS ANTICIPATED Q4 2023
* LYRA THERAPEUTICS - ANTICIPATE CASH, CASH EQUIVALENTS,
SHORT-TERM INVESTMENT BALANCE IS SUFFICIENT TO FUND OPERATING
EXPENSES & CAPEX INTO MID-Q2 OF 2024
* LYRA THERAPEUTICS INC QTRLY LOSS PER SHARE $0.44
Source text for Eikon: ID:nGNX1Zp0lF
Further company coverage: LYRA.O
((Reuters.Briefs@thomsonreuters.com;))